Search research articles
Contact Us
Filters
Showing results (11-20 of 71) with videos related to
Page
of 8
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)
|
February 27, 2004
NC-531 (Neurochem)
Hugo Geerts
Expert Opinion on Investigational Drugs
|
November 4, 2011
α7 Nicotinic receptor modulators for cognitive deficits in schizophrenia and Alzheimer's disease
Hugo Geerts
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 8, 2020
Learning from amyloid trials in Alzheimer's disease. A virtual patient analysis using a quantitative systems pharmacology approach
Hugo Geerts, Athan Spiros
Journal of Alzheimer'S Disease : JAD
|
October 5, 2020
Simulating the Effects of Common Comedications and Genotypes on Alzheimer's Cognitive Trajectory Using a Quantitative Systems Pharmacology Approach
Hugo Geerts, Athan Spiros
Future Medicinal Chemistry
|
January 10, 2015
Multitarget drug discovery projects in CNS diseases: quantitative systems pharmacology as a possible path forward
Hugo Geerts, Ludo Kennis
Frontiers in Neuroscience
|
October 18, 2021
Toward Predicting Impact of Common Genetic Variants on Schizophrenia Clinical Responses With Antipsychotics: A Quantitative System Pharmacology Study
Athan Spiros, Hugo Geerts
Journal of Experimental Pharmacology
|
May 18, 2016
A quantitative way to estimate clinical off-target effects for human membrane brain targets in CNS research and development
Athan Spiros, Hugo Geerts
Journal of Clinical Pharmacology
|
July 1, 2006
Pharmacology of acetylcholinesterase inhibitors and N-methyl-D-aspartate receptors for combination therapy in the treatment of Alzheimer's disease
Hugo Geerts, George T Grossberg
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Hugo Geerts, Shaina M Short
Frontiers in Neuroscience
|
August 6, 2019
Neuronal Circuit-Based Computer Modeling as a Phenotypic Strategy for CNS R&D
Hugo Geerts, James E Barrett
Page
of 8
Search research articles
Search
Showing results (11-20 of 71) with videos related to
Sort By:
Page
of 8
Current Opinion in Investigational Drugs (London, England : 2000)
|
February 27, 2004
NC-531 (Neurochem)
Hugo Geerts
Expert Opinion on Investigational Drugs
|
November 4, 2011
α7 Nicotinic receptor modulators for cognitive deficits in schizophrenia and Alzheimer's disease
Hugo Geerts
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 8, 2020
Learning from amyloid trials in Alzheimer's disease. A virtual patient analysis using a quantitative systems pharmacology approach
Hugo Geerts, Athan Spiros
Journal of Alzheimer'S Disease : JAD
|
October 5, 2020
Simulating the Effects of Common Comedications and Genotypes on Alzheimer's Cognitive Trajectory Using a Quantitative Systems Pharmacology Approach
Hugo Geerts, Athan Spiros
Future Medicinal Chemistry
|
January 10, 2015
Multitarget drug discovery projects in CNS diseases: quantitative systems pharmacology as a possible path forward
Hugo Geerts, Ludo Kennis
Frontiers in Neuroscience
|
October 18, 2021
Toward Predicting Impact of Common Genetic Variants on Schizophrenia Clinical Responses With Antipsychotics: A Quantitative System Pharmacology Study
Athan Spiros, Hugo Geerts
Journal of Experimental Pharmacology
|
May 18, 2016
A quantitative way to estimate clinical off-target effects for human membrane brain targets in CNS research and development
Athan Spiros, Hugo Geerts
Journal of Clinical Pharmacology
|
July 1, 2006
Pharmacology of acetylcholinesterase inhibitors and N-methyl-D-aspartate receptors for combination therapy in the treatment of Alzheimer's disease
Hugo Geerts, George T Grossberg
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Hugo Geerts, Shaina M Short
Frontiers in Neuroscience
|
August 6, 2019
Neuronal Circuit-Based Computer Modeling as a Phenotypic Strategy for CNS R&D
Hugo Geerts, James E Barrett
Page
of 8